Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q7ZUM8

Entry ID Method Resolution Chain Position Source
AF-Q7ZUM8-F1 Predicted AlphaFoldDB

No variants for Q7ZUM8

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q7ZUM8

No associated diseases with Q7ZUM8

5 regional properties for Q7ZUM8

Type Name Position InterPro Accession
domain Peptidase C19, ubiquitin carboxyl-terminal hydrolase 295 - 681 IPR001394
domain Zinc finger, UBP-type 2 - 99 IPR001607
conserved_site Ubiquitin specific protease, conserved site 296 - 311 IPR018200-1
conserved_site Ubiquitin specific protease, conserved site 625 - 643 IPR018200-2
domain Ubiquitin specific protease domain 295 - 684 IPR028889

Functions

Description
EC Number 3.4.19.12 Omega peptidases
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

2 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

2 GO annotations of molecular function

Name Definition
cysteine-type deubiquitinase activity An thiol-dependent isopeptidase activity that cleaves ubiquitin from a target protein to which it is conjugated.
zinc ion binding Binding to a zinc ion (Zn).

7 GO annotations of biological process

Name Definition
cell cycle The progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. Canonically, the cell cycle comprises the replication and segregation of genetic material followed by the division of the cell, but in endocycles or syncytial cells nuclear replication or nuclear division may not be followed by cell division.
cell division The process resulting in division and partitioning of components of a cell to form more cells; may or may not be accompanied by the physical separation of a cell into distinct, individually membrane-bounded daughter cells.
central nervous system morphogenesis The process in which the anatomical structure of the central nervous system is generated and organized. The central nervous system is the core nervous system that serves an integrating and coordinating function. In vertebrates it consists of the brain and spinal cord. In those invertebrates with a central nervous system it typically consists of a brain, cerebral ganglia and a nerve cord.
cranial skeletal system development The process whose specific outcome is the progression of a cranial skeletal system over time, from its formation to the mature structure. The cranial skeletal system is the skeletal subdivision of the head, and includes the skull (cranium plus mandible), pharyngeal and/or hyoid apparatus.
negative regulation of ubiquitin protein ligase activity Any process that stops, prevents or reduces the frequency, rate or extent of ubiquitin protein ligase activity.
protein deubiquitination The removal of one or more ubiquitin groups from a protein.
ubiquitin-dependent protein catabolic process The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of a ubiquitin group, or multiple ubiquitin groups, to the protein.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MDRCKHVGRL RLAQDHSILN PQKWHCVDCN TTESVWACLS CSHVACGRYI EEHALQHFKE
70 80 90 100 110 120
QHHPLALEVN ELYVYCYLCD DYVLNDNATG DLKLLRSTLS AIKSQCYEVT TRSGRTLRSS
130 140 150 160 170 180
SANGDQLSPS TQELQLRDED RMFTALWHRR RALIGRLFRL WFAQTERGKK RLEEERQQEE
190 200 210 220 230 240
EEERKREARE RRRQLKRQLK EELESAPPRK SHRIRRQSLK ATSVKPARAP AKSTKSVRRR
250 260 270 280 290 300
SAPARVSTPT PRTPRERTPQ QRPRPQAKAK RPQAPPSKTG DSPVKRRPTV TPGVTGLRNL
310 320 330 340 350 360
GNTCYMNSIL QVLSHLHVFR ECFLRLDLNQ ALELLASAVS RKLGLSAQRV IQPKGLNQGS
370 380 390 400 410 420
GLSGGASRSR NMELIQPKEP SSKHISLCHE LHTLFPVMWS GKWALVSPFA MLHSVWQLIP
430 440 450 460 470 480
AFRGYAQQDA QEFLCELLDK VQHELERTRT LTPATVPANQ RRLIKQVLSV VNTIFHGQLL
490 500 510 520 530 540
SQVRCLACDH RSNTIEPFWD LSLEFPERYH SNSKDAAQVP CGLTEMLAKF TETEALEGAI
550 560 570 580 590 600
YACDYCNNKR RRFCSKQVVL TEAQKQLMVH KLPHVLRLHL KRFRWSGRNH REKIGVHVQF
610 620 630 640 650 660
EQELNMEPYC CKDSGNLPHP QHFLYQLSAV VMHHGKGFGS GHYTAFCYNT EGGFWVHCND
670 680 690
SKLSVCAVEE VCKAQAYILF YTQRNAQDKS KESDL